MOH — Molina Healthcare Inc price, chart and key statistics

Price data

Price

$209.49

YTD price return

+20.72%

YTD total return

+20.72%

Market cap

10.9B2016-12 3.1B2026-11 10.9B+254.8% over the window

Enterprise value

6.4B

Shares outstanding

52.2M2016-09 56.8M2026-09 52.2M-8.1% over the window

52W low

$121.06

52W high

$244.89

From 52W high

-14.46%

From 52W low

+73.05%

52W range

71%$121–$245

Beta

0.74

Volume

Rel volume

0.39×

30D volume

919.9K

30D $ vol

191.9M

Insider trading

Insider net 1W0 insider-days of buying (no priced lot) and 3 of selling ($2.1M) in the last 7 days, by transaction date, open-market transactions only — awards, exercises, tax withholding and employee-plan purchases are not counted. A Form 4 is filed within two business days of the trade, so the newest days may not be in yet.

−$2.1M

Insider net 1M0 insider-days of buying (no priced lot) and 3 of selling ($2.1M) in the last 30 days, by transaction date, open-market transactions only — awards, exercises, tax withholding and employee-plan purchases are not counted. A Form 4 is filed within two business days of the trade, so the newest days may not be in yet.

−$2.1M

Insider net 3M0 insider-days of buying (no priced lot) and 3 of selling ($2.1M) in the last 91 days, by transaction date, open-market transactions only — awards, exercises, tax withholding and employee-plan purchases are not counted. A Form 4 is filed within two business days of the trade, so the newest days may not be in yet.

−$2.1M

Insider net 1Y1 insider-day of buying ($100K) and 6 of selling ($5.6M) in the last 365 days, by transaction date, open-market transactions only — awards, exercises, tax withholding and employee-plan purchases are not counted. A Form 4 is filed within two business days of the trade, so the newest days may not be in yet.

−$5.5M

Form 4 transactions by trade date, as filed; latest on file 2026-11-13.

Fundamentals

Sales (ttm)

44.1B2016-09 17.1B2026-09 44.1B+157.8% over the window

Sales/share

$845.342016-09 $301.282026-09 $845.34+180.6% over the window

EPS (ttm)

-$0.942016-09 $2.292026-09 -$0.94-141.0% over the window

FCF (ttm)

238M2016-09 678M2026-09 238M-64.9% over the window

FCF/share

$4.562016-09 $11.932026-09 $4.56-61.8% over the window

Book value/share

$79.602016-09 $29.762026-09 $79.60+167.5% over the window

Net margin

-0.11%2016-09 0.8%2026-09 -0.1%-114.4% over the window

ROE

-1.16%2016-09 7.6%2026-09 -1.2%-115.1% over the window

ROA

-0.31%2016-09 1.7%2026-09 -0.3%-118.0% over the window

Debt / equity

0.91×2016-09 0.572026-09 0.91+58.1% over the window

Current ratio

1.692016-09 1.312026-09 1.69+29.2% over the window

Growth (CAGR, ttm) · 10Y

Sales

-0.95%2025-09-30 → 2026-09-3044.5B → 44.1B (-0.9% total)+9.89%2023-09-30 → 2026-09-3033.2B → 44.1B (+32.7% total)+11.51%2021-09-30 → 2026-09-3025.6B → 44.1B (+72.4% total)+9.93%2016-09-30 → 2026-09-3017.1B → 44.1B (+157.8% total)

FCF

n/a-51.14%2023-09-30 → 2026-09-302B → 238M (-88.3% total)-38.73%2021-09-30 → 2026-09-302.8B → 238M (-91.4% total)-9.94%2016-09-30 → 2026-09-30678M → 238M (-64.9% total)

Shares

+1.56%2025-09-30 → 2026-09-3051.4M → 52.2M (+1.6% total)-3.62%2023-09-30 → 2026-09-3058.3M → 52.2M (-10.5% total)-2.22%2021-09-30 → 2026-09-3058.4M → 52.2M (-10.6% total)-0.84%2016-09-30 → 2026-09-3056.8M → 52.2M (-8.1% total)

Per-share growth (CAGR, ttm) · 10Y

Sales/share

-2.47%2025-09-30 → 2026-09-30$866.73 → $845.34 (-2.5% total)+14.02%2023-09-30 → 2026-09-30$570.27 → $845.34 (+48.2% total)+14.04%2021-09-30 → 2026-09-30$438.30 → $845.34 (+92.9% total)+10.87%2016-09-30 → 2026-09-30$301.28 → $845.34 (+180.6% total)

FCF/share

n/a-49.30%2023-09-30 → 2026-09-30$35.01 → $4.56 (-87.0% total)-37.34%2021-09-30 → 2026-09-30$47.17 → $4.56 (-90.3% total)-9.17%2016-09-30 → 2026-09-30$11.93 → $4.56 (-61.8% total)

Book value/share

-2.38%2025-09-30 → 2026-09-30$81.54 → $79.60 (-2.4% total)+6.16%2023-09-30 → 2026-09-30$66.54 → $79.60 (+19.6% total)+13.05%2021-09-30 → 2026-09-30$43.12 → $79.60 (+84.6% total)+10.34%2016-09-30 → 2026-09-30$29.76 → $79.60 (+167.5% total)

Price

+51.32%2025-11-13 → 2026-11-13$138.48 → $209.49 (+51.3% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-16.60%2023-11-13 → 2026-11-13$361.13 → $209.49 (-42.0% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-7.73%2021-11-12 → 2026-11-13$313.22 → $209.49 (-33.1% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+15.98%2016-11-11 → 2026-11-13$47.53 → $209.49 (+340.8% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.

Total return

+51.32%2025-11-13 → 2026-11-13$138.48 → $209.49 (+51.3% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-16.60%2023-11-13 → 2026-11-13$361.13 → $209.49 (-42.0% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-7.73%2021-11-12 → 2026-11-13$313.22 → $209.49 (-33.1% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+15.98%2016-11-11 → 2026-11-13$47.53 → $209.49 (+340.8% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.

-223.2×2016-12 23.902026-11 -227.87-1053.4% over the window

P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.

63.6×2016-12 7.952026-11 63.59+700.3% over the window

Fwd P/E

21.6×

P/S (ttm)Market cap ÷ TTM revenue.

0.2×2016-12 0.182026-11 0.25+37.6% over the window

P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.

2.6×2016-12 1.822026-11 2.63+44.4% over the window

P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).

45.9×2016-12 4.552026-11 45.96+910.7% over the window

EV/EBITDA (fy)

19.2×

EV/Sales (ttm)

0.1×

FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.

2.18%2016-09 22.0%2026-09 2.4%-89.0% over the window

Buyback yield (realized, 1y)1 − shares_at(2026-09-30) ÷ shares_at(2025-09-30) = 1 − 52.2M ÷ 51.4M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.

-1.56%

Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-1.56%) + dividends paid over that year ($0) ÷ market_cap_at(2025-09-30) ($9.8B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.

-1.56%

Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($0) ÷ today's market cap ($10.9B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.

0.00%2016-09 0.0%2026-09 0.0%

Shareholder yield (cash, ttm)(TTM buybacks net of issuance $0 + TTM dividends $0) ÷ today's market cap ($10.9B). Same caveat as the cash buyback yield.

0.00%2016-09 0.0%2026-09 0.0%

Vs own 10Y history

P/E

99th

P/OI

100th

P/S

25th

P/B

21st

P/FCF

93rd